Celanese Corp: Form 10-Q for the period ended Mar 31, 2017
Filed with the SEC on Apr 18, 2017 and accepted by EDGAR at Apr 18, 2017, 16:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $1.47bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-01-01 to 2017-03-31 | $1.12bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-01-01 to 2017-03-31 | $352.0m | us-gaap:GrossProfit |
| Research and development | 3 months2017-01-01 to 2017-03-31 | $17.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-01-01 to 2017-03-31 | $83.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-01-01 to 2017-03-31 | $192.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-01-01 to 2017-03-31 | $29.0m | us-gaap:InterestExpense |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $56.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | $183.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | $1.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-01-01 to 2017-03-31 | $1.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-01-01 to 2017-03-31 | 140,997,403 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2017-01-01 to 2017-03-31 | $192.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2017-01-01 to 2017-03-31 | $62.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2017-01-01 to 2017-03-31 | $51.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2017-01-01 to 2017-03-31 | $128.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-03-31 | $501.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $2.39bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $8.29bn | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $1.01bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2017-03-31 | $2.85bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-03-31 | $107.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2017-03-31 | $2.61bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-17-000124. Last ingested by Listed: Nov 13, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.